Pregabalin 150 mg oral capsules can have a wide price range depending on factors such as brand name versus generic, dosage, quantity, and pharmacy.
How much does generic pregabalin cost?
The cost of generic pregabalin 150 mg is significantly lower than its brand-name equivalent. For example, a 30-day supply of 150 mg generic pregabalin capsules might cost anywhere from $10 to $40, whereas the brand-name version could cost $100 or more for the same quantity [1]. Prices can vary between different pharmacies and whether a prescription discount card or coupon is used.
What is the brand name for pregabalin and how does its price compare?
The brand name for pregabalin is Lyrica. Lyrica is typically more expensive than generic pregabalin. For instance, a 30-day supply of Lyrica 150 mg could cost upwards of $150 without insurance [1]. The price difference is largely due to patent protection that initially allowed the brand-name drug to command a higher price.
When did the patent for Lyrica expire?
The primary patents for Lyrica have expired in major markets, leading to the availability of generic versions. For instance, in the United States, the last key patent expired around mid-2019, opening the door for generic competition [2]. This patent expiration is a major reason for the decrease in overall pregabalin costs.
How do insurance plans affect pregabalin pricing?
Insurance coverage can significantly reduce the out-of-pocket cost for both brand-name Lyrica and generic pregabalin. Copayments for generic pregabalin are typically low, often in the $10 to $30 range, while brand-name Lyrica might still have a higher copay or require prior authorization [1]. It is advisable to check with your specific insurance provider for their formulary and copay details.
Are there other ways to get cheaper pregabalin?
Patients may find ways to reduce costs by comparing prices at different pharmacies, using prescription discount cards, or looking for patient assistance programs offered by manufacturers. Online pharmacies can sometimes offer competitive pricing as well, though it is important to ensure they are licensed and reputable.
Sources:
1. DrugPatentWatch.com
2. "Lyrica." DrugPatentWatch.com